Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 17,707 shares of the company’s stock, valued at approximately $992,000. Compass Wealth Management LLC owned 0.34% of SPDR S&P Pharmaceuticals ETF as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Envestnet Asset Management Inc. purchased a new position in SPDR S&P Pharmaceuticals ETF during the third quarter worth approximately $10,732,000. UBS Group AG raised its stake in SPDR S&P Pharmaceuticals ETF by 33.2% during the fourth quarter. UBS Group AG now owns 47,961 shares of the company’s stock worth $2,686,000 after purchasing an additional 11,948 shares during the period. Clark Capital Management Group Inc. purchased a new position in SPDR S&P Pharmaceuticals ETF during the third quarter worth approximately $2,248,000. Envestnet Portfolio Solutions Inc. raised its stake in SPDR S&P Pharmaceuticals ETF by 2.0% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 175,309 shares of the company’s stock worth $9,819,000 after purchasing an additional 3,379 shares during the period. Finally, Stephens Inc. AR purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $229,000.
SPDR S&P Pharmaceuticals ETF Stock Up 0.1%
NYSEARCA:XPH opened at $58.36 on Thursday. The company has a market cap of $358.91 million, a P/E ratio of 14.28 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $40.26 and a fifty-two week high of $60.73. The firm’s 50 day moving average is $57.32 and its two-hundred day moving average is $56.27.
SPDR S&P Pharmaceuticals ETF Company Profile
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
